In this review, we suggest the use of a panel consisting of eight tumor-associated biomarkers—CEA, CYFRA21-1, ProGRP, CEA, PSF3, MUC, SCCA, and SST—allow us to differentiate between each histological type of lung cancer and to define the metastasis rate. This evidence concerns the gene GRP and lung carcinoma.